156
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Estimation of Generalized Impact Fraction and Population Attributable Fraction of Hypertension Based on JNC-IV and 2017 ACC/AHA Guidelines for Cardiovascular Diseases Using Parametric G-Formula: Tehran Lipid and Glucose Study (TLGS)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1015-1028 | Published online: 05 Aug 2020

References

  • Esteghamati A, Etemad K, Koohpayehzadeh J, et al. Awareness, treatment and control of pre-hypertension and hypertension among adults in Iran. Arch Iran Med. 2016;19(7):456–464. doi:0161907/AIM.00327362238
  • Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423. doi:10.1136/bmjopen-2013-003423
  • Whelton. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71(6):E136–E139. doi:10.1161/HYP.000000000000007529743246
  • Asgari S, Khaloo P, Khalili D, Azizi F, Hadaegh F. Status of hypertension in Tehran: potential impact of the ACC/AHA 2017 and JNC7 guidelines, 2012–2015. Sci Rep. 2019;9(1):6382. doi:10.1038/s41598-019-42809-331011156
  • Kim HC, Jeon YW, Heo ST. Global impact of the 2017 American College of Cardiology/American Heart Association hypertension guidelines. Circulation. 2018;138(21):2312–2314. doi:10.1161/CIRCULATIONAHA.118.03631230571579
  • Rothman KJ, Greenland S. Modern Epidemiology. Lippincott Williams& Wilkins; 2008.
  • Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9(3):531–541.13124110
  • Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971;25(4):242–244. doi:10.1136/jech.25.4.2425160433
  • Khosravi A, Mansournia MA. Recommendation on unbiased estimation of population attributable fraction calculated in “prevalence and risk factors of active pulmonary tuberculosis among elderly people in China: a population based cross-sectional study”. Infect Dis Poverty. 2019;8(1). doi:10.1186/s40249-019-0587-8
  • Mansournia MA, Altman DG. Population attributable fraction. BMJ (Online). 2018;360.
  • Greenland S. Estimating standardized parameters from generalized linear models. Stat Med. 1991;10(7):1069–1074. doi:10.1002/sim.47801007071876795
  • Gharibzadeh S, Mohammad K, Rahimiforoushani A, Amouzegar A, Mansournia MA. Standardization as a tool for causal inference in medical research. Arch Iran Med. 2016;19(9):0–0.
  • van der Wal WM, Prins M, Lumbreras B, Geskus R. A simple G‐computation algorithm to quantify the causal effect of a secondary illness on the progression of a chronic disease. Stat Med. 2009;28(18):2325–2337. doi:10.1002/sim.362919499549
  • Snowden JM, Rose S, Mortimer KM. Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. Am J Epidemiol. 2011;173(7):731–738. doi:10.1093/aje/kwq47221415029
  • Taubman SL, Robins JM, Mittleman MA, Hernán MA. Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol. 2009;38(6):1599–1611. doi:10.1093/ije/dyp19219389875
  • Azizi F, Rahmani M, Emami H, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 2002;47(6):408–426. doi:10.1007/s00038020000812643001
  • Organization WH. Cerebrovascular Disorders: A Clinical and Research Classification. World Health Organization; 1978.
  • National Document for the Prevention and Control of Non-Communicable Diseases and Related Risk Factors in the Islamic Republic of Iran, from 2015 to 2025. Tehran 2015:81.
  • Qi Y, Han X, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline. J Am Coll Cardiol. 2018;72(11):1201–1210. doi:10.1016/j.jacc.2018.06.05630189996
  • Hernández-Vásquez A, Santero M. New 2017 ACC/AHA hypertension guideline: implications for a Latin American country like Peru. Eur J Prev Cardiol. 2019;26(6):668–670. doi:10.1177/204748731879948930180757
  • Muntner P, Carey RM, Gidding S, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018;137(2):109–118. doi:10.1161/CIRCULATIONAHA.117.03258229133599
  • Garies S, Hao S, McBrien K, et al. Prevalence of hypertension, treatment, and blood pressure targets in Canada associated with the 2017 American College of Cardiology and American Heart Association blood pressure guidelines. JAMA Netw Open. 2019;2(3):e190406–e190406. doi:10.1001/jamanetworkopen.2019.040630848811
  • Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.03238029449338
  • Al Kibria GM, Swasey K, Hasan MZ, et al. Determinants of hypertension among adults in Bangladesh as per the Joint National Committee 7 and 2017 American College of Cardiology/American Hypertension Association hypertension guidelines. J Am Soc Hypertens. 2018;12(11):e45–e55. doi:10.1016/j.jash.2018.10.00430416080
  • Talaei M, Hosseini N, Koh AS, Yuan JM, Koh WP. Association of “elevated blood pressure” and “stage 1 hypertension” with cardiovascular mortality among an Asian population. J Am Heart Assoc. 2018;7(8):e008911. doi:10.1161/JAHA.118.00891129636346
  • Atasoy S, Johar H, Peters A, Ladwig K-H. Association of hypertension cut-off values with 10-year cardiovascular mortality and clinical consequences: a real-world perspective from the prospective MONICA/KORA study. Eur Heart J. 2019;40(9):732–738. doi:10.1093/eurheartj/ehy69430462213
  • Son JS, Choi S, Kim K, et al. Association of blood pressure classification in Korean young adults according to the 2017 American College of Cardiology/American Heart Association guidelines with subsequent cardiovascular disease events. JAMA. 2018;320(17):1783–1792. doi:10.1001/jama.2018.1650130398603
  • McEvoy JW, Daya N, Rahman F, et al. Association of isolated diastolic hypertension as defined by the 2017 ACC/AHA blood pressure guideline with incident cardiovascular outcomes. JAMA. 2020;323(4):329–338. doi:10.1001/jama.2019.2140231990314
  • Wang M, Wu T, Yu C, et al. Association between blood pressure levels and cardiovascular deaths: a 20-year follow-up study in rural China. BMJ Open. 2020;10(2):e035190–e035190. doi:10.1136/bmjopen-2019-035190
  • Gao J, Dai Y, Xie Y, et al. The association of stage 1 hypertension defined by the 2017 ACC/AHA guideline with stroke and its subtypes among elderly Chinese. Biomed Res Int. 2020;2020:4023787. doi:10.1155/2020/402378732149103
  • Han M, Chen Q, Liu L, et al. Stage 1 hypertension by the 2017 American College of Cardiology/American Heart Association hypertension guidelines and risk of cardiovascular disease events: systematic review, meta-analysis, and estimation of population etiologic fraction of prospective cohort studies. J Hypertens. 2020;38(4):573–578. doi:10.1097/HJH.000000000000232131790053
  • Johnson HM, Warner RC, LaMantia JN, Bowers BJ. “I have to live like I’m old.” Young adults’ perspectives on managing hypertension: a multi-center qualitative study. BMC Fam Pract. 2016;17(1):31. doi:10.1186/s12875-016-0428-926969619
  • Trajkova S, d’Errico A, Ricceri F, et al. Impact of preventable risk factors on stroke in the EPICOR study: does gender matter? Int J Public Health. 2017;62(7):775–786. doi:10.1007/s00038-017-0993-228643029
  • Kaur P, Ramachandra Rao S, Venkatachalam R, et al. Risk factors for cardiovascular disease in rural South India: cohort study. BMJ Open. 2019;9(10):e029759. doi:10.1136/bmjopen-2019-029759
  • Félix-Redondo FJ, Lozano Mera L, Alvarez-Palacios Arrighi P, Grau Magana M, Ramírez-Romero JM, Fernández-Bergés D. Impact of cardiovascular risk factors in the Extremadura population: HERMEX cohort contributions for a preventive strategy. Atencion Primaria. 2020;52(1):3–13. doi:10.1016/j.aprim.2018.11.00630638699
  • Sardarinia M, Akbarpour S, Lotfaliany M, et al. Risk factors for incidence of cardiovascular diseases and all-cause mortality in a middle eastern population over a decade follow-up: Tehran lipid and glucose study. PLoS One. 2016;11(12):e0167623. doi:10.1371/journal.pone.016762327930696
  • Dong K, Yang Q, Duan F, et al. Stroke and (or) myocardial infarction attributable to modifiable risk factors in Henan, China. J Am Soc Hypertens. 2018;12(7):524–533. doi:10.1016/j.jash.2018.03.01329699875
  • O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi:10.1016/S0140-6736(16)30506-227431356
  • Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967. doi:10.1016/S0140-6736(15)01225-826724178
  • Hussain MA, Al Mamun A, Peters SA, Woodward M, Huxley RR. The burden of cardiovascular disease attributable to major modifiable risk factors in Indonesia. J Epidemiol. 2016;26(10):515–521. doi:10.2188/jea.JE2015017827021286
  • Redon J, Tellez-Plaza M, Orozco-Beltran D, et al. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study. J Hypertens. 2016;34(6):1075–1083. doi:10.1097/HJH.000000000000093027074896
  • Clark D, Colantonio LD, Min YI, et al. Population-attributable risk for cardiovascular disease associated with hypertension in black adults. JAMA Cardiol. 2019;4(12):1194–1202. doi:10.1001/jamacardio.2019.377331642869
  • Shadmani FK, Karami M. Joint effect of modifying selected risk factors on attributable burden of cardiovascular diseases. Int J Prev Med. 2013;4(12):1461–1467.24498503
  • Mazloumi E, Poorolajal J, Sarrafzadegan N, Roohafza HR, Faradmal J, Karami M. Avoidable burden of cardiovascular diseases in the eastern mediterranean region: contribution of selected risk factors for cardiovascular-related deaths. High Blood Pressure Cardiovasc Prev. 2019;26(3):227–237. doi:10.1007/s40292-019-00319-3
  • Khosravi A, Nielsen RO, Mansournia MA. Methods matter: population attributable fraction (PAF) in sport and exercise medicine. Br J Sports Med. 2020;bjsports-2020-101977.
  • Zhang C-Y, Zhao F, Xia -Y-Y, et al. Prevalence and risk factors of active pulmonary tuberculosis among elderly people in China: a population based cross-sectional study. Infect Dis Poverty. 2019;8(1):7. doi:10.1186/s40249-019-0515-y30654836
  • Lin C-K, Lin R-T, Chen T, Zigler C, Wei Y, Christiani DC. A global perspective on coal-fired power plants and burden of lung cancer. Environ Health. 2019;18(1):9. doi:10.1186/s12940-019-0448-830691464
  • Cai Z, Brumback BA. Model‐based standardization to adjust for unmeasured cluster‐level confounders with complex survey data. Stat Med. 2015;34(15):2368–2380. doi:10.1002/sim.650425851438
  • Mokhayeri Y, Hashemi-Nazari SS, Khodakarim S, et al. Effects of hypothetical interventions on ischemic stroke using parametric G-formula. Stroke. 2019;50(11):3286–3288. doi:10.1161/STROKEAHA.119.02574931480969
  • Vangen-Lonne AM, Ueda P, Gulayin P, Wilsgaard T, Mathiesen EB, Danaei G. Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population. Eur J Epidemiol. 2018;33(6):557–566. doi:10.1007/s10654-017-0344-x29294206
  • O’Neill KN, Fitzgerald AP, Kearney PM. Impact of population distribution shifts in sugar-sweetened beverage consumption on type II diabetes incidence in Ireland. Ann Epidemiol. 2020;41:1–6. doi:10.1016/j.annepidem.2019.12.00731928896
  • Jain P, Suemoto CK, Rexrode K, et al. Hypothetical lifestyle strategies in middle-aged women and the long-term risk of stroke. Stroke. 2020;51(5):1381–1387. doi:10.1161/STROKEAHA.119.02676132268852